ACC/AHA Versus ESC/ESH on Hypertension Guidelines

被引:207
作者
Bakris, George [1 ]
Ali, Waleed [1 ]
Parati, Gianfranco [2 ,3 ]
机构
[1] Univ Chicago Med, Sect Endocrinol Diabet & Metab, AHA Comprehens Hypertens Ctr, Dept Med, Chicago, IL USA
[2] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy
[3] IRCCS, Ist Auxol Italiano, Dept Cardiovasc Neural & Metab Sci, Milan, Italy
关键词
blood pressure; guidelines; hypertension; lifestyle; mortality; outcomes; PRESSURE-LOWERING TREATMENT; ASSOCIATION TASK-FORCE; BLOOD-PRESSURE; COMBINATION THERAPY; AMERICAN-COLLEGE; MANAGEMENT;
D O I
10.1016/j.jacc.2019.03.507
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study compares the recommendations of the most recent American College of Cardiology (ACC)/American Heart Association (AHA) and European Society of Cardiology (ESC)/European Society of Hypertension (ESH) blood pressure guidelines. Both guidelines represent updates of previous guidelines and reinforce previous concepts of prevention regarding elevated blood pressure. Specifically, a low-sodium diet, exercise, body weight reduction, low to moderate alcohol intake, and adequate potassium intake are emphasized. Overall, both guidelines agree on the proper method of blood pressure measurement, the use of home blood pressure and ambulatory monitoring, and restricted use of beta-blockers as first-line therapy. The major disagreements are with the level of blood pressure defining hypertension, flexibility in identifying blood pressure targets for treatment, and the use of initial combination therapy. Although initial single-pill combination therapy is strongly recommended in both guidelines, the ESC/ESH guideline recommends it as initial therapy in patients at >= 140/90 mm Hg. The ACC/AHA guideline recommends its use in patients >20/10 mm Hg above blood pressure goal. Thus, the only real disagreement is that the ACC/AHA guidelines maintain that all people with blood pressure >130/80 mm Hg have hypertension, and blood pressure should be lowered to <130/80 mm Hg in all. In contrast, the ESC/ESH guidelines state that hypertension is defined as >140/90 mm Hg, with the goal being a level <140/90 mm Hg for all targeting to <130/80 mm Hg only in those at high cardiovascular risk, but always considering individual tolerability of the proposed goal. (C) 2019 by the American College of Cardiology Foundation.
引用
收藏
页码:3018 / 3026
页数:9
相关论文
共 31 条
  • [1] American Diabetes Association, 2019, Diabetes Care, V42, pS103, DOI 10.2337/dc19-S010
  • [2] Attended and Unattended Automated Office Blood Pressure Measurements Have Better Agreement With Ambulatory Monitoring Than Conventional Office Readings
    Andreadis, Emmanuel A.
    Geladari, Charalampia V.
    Angelopoulos, Epameinondas T.
    Savva, Florentia S.
    Georgantoni, Anna I.
    Papademetriou, Vasilios
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [3] [Anonymous], 1977, JAMA, DOI DOI 10.1001/JAMA.1977.03270300059008
  • [4] The Implications of Blood Pressure Measurement Methods on Treatment Targets for Blood Pressure
    Bakris, George L.
    [J]. CIRCULATION, 2016, 134 (13) : 904 - 905
  • [5] White-coat UnControlled Hypertension, Masked UnControlled Hypertension, and True UnControlled Hypertension, phonetic and mnemonic terms for treated hypertension phenotypes
    Banegas, Jose R.
    Ruilope, Luis M.
    Williams, Bryan
    [J]. JOURNAL OF HYPERTENSION, 2018, 36 (02) : 446 - 447
  • [6] Treatment of hypertension in patients 80 years of age or older
    Beckett, Nigel S.
    Peters, Ruth
    Fletcher, Astrid E.
    Staessen, Jan A.
    Liu, Lisheng
    Dumitrascu, Dan
    Stoyanovsky, Vassil
    Antikainen, Riitta L.
    Nikitin, Yuri
    Anderson, Craig
    Belhani, Alli
    Forette, Francoise
    Rajkumar, Chakravarthi
    Thijs, Lutgarde
    Banya, Winston
    Bulpitt, Christopher J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18) : 1887 - 1898
  • [7] Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control
    Beddhu, Srinivasan
    Chertow, Glenn M.
    Cheung, Alfred K.
    Cushman, William C.
    Rahman, Mahboob
    Greene, Tom
    Wei, Guo
    Campbell, Ruth C.
    Conroy, Margaret
    Freedman, Barry I.
    Haley, William
    Horwitz, Edward
    Kitzman, Dalane
    Lash, James
    Papademetriou, Vasilios
    Pisoni, Roberto
    Riessen, Erik
    Rosendorff, Clive
    Watnick, Suzanne G.
    Whittle, Jeffrey
    Whelton, Paul K.
    [J]. CIRCULATION, 2018, 137 (02) : 134 - 143
  • [8] Incremental Benefits and Harms of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline
    Bell, Katy J. L.
    Doust, Jenny
    Glasziou, Paul
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (06) : 755 - 757
  • [9] Individualizing Blood Pressure Targets for People With Diabetes and Hypertension Comparing the ADA and the ACC/AHA Recommendations
    de Boer, Ian H.
    Bakris, George
    Cannon, Christopher P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (13): : 1319 - 1320
  • [10] Diabetes and Hypertension: A Position Statement by the American Diabetes Association
    de Boer, Ian H.
    Bangalore, Sripal
    Benetos, Athanase
    Davis, Andrew M.
    Michos, Erin D.
    Muntner, Paul
    Rossing, Peter
    Zoungas, Sophia
    Bakris, George
    [J]. DIABETES CARE, 2017, 40 (09) : 1273 - 1284